| European Case Law Identifier: | ECLI:EP:BA:2004:T106702.20041130 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 30 November 2004 | ||||||||
| Case number: | T 1067/02 | ||||||||
| Application number: | 92900779.7 | ||||||||
| IPC class: | G01N 33/53 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Proteins with changed epitopes and methods for the production thereof | ||||||||
| Applicant name: | Novozymes A/S | ||||||||
| Opponent name: | (01) Baxter Aktiengesellschaft (02) Genentech, Inc. (03) GENENCOR INTERNATIONAL INC. |
||||||||
| Board: | 3.3.08 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main request - added subject-matter (yes) First and second auxiliary requests - extension of protection (yes) Third, fourth and fifth auxiliary requests - added subject- matter (yes) Sixth auxiliary request - extension of protection (yes) Seventh auxiliary request - added subject-matter (no), extension of protection (no), sufficiency of disclosure (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t021067eu1.html
Date retrieved: 17 May 2021